Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 282 entries
Sorted by: Best Match Show Resources per page
Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (.

Allergo journal international

Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF.
PMID: 26120552
Allergo J Int. 2015;24(3):94-105. doi: 10.1007/s40629-015-0052-6.

Drug hypersensitivity reactions are unpredictable adverse drug reactions. They manifest either within 1-6 h following drug intake (immediate reactions) with mild to life-threatening symptoms of anaphylaxis, or several hours to days later (delayed reactions), primarily as exanthematous eruptions. It...

Cite
Brockow K, Przybilla B, Aberer W, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (. Allergo J Int. 2015;24(3):94-105doi: 10.1007/s40629-015-0052-6.
Brockow, K., Przybilla, B., Aberer, W., Bircher, A. J., Brehler, R., Dickel, H., Fuchs, T., Jakob, T., Lange, L., Pfützner, W., Mockenhaupt, M., Ott, H., Pfaar, O., Ring, J., Sachs, B., Sitter, H., Trautmann, A., Treudler, R., Wedi, B., Worm, M., Wurpts, G., Zuberbier, T., & Merk, H. F. (2015). Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (. Allergo journal international, 24(3), 94-105. https://doi.org/10.1007/s40629-015-0052-6
Brockow, Knut, et al. "Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (." Allergo journal international vol. 24,3 (2015): 94-105. doi: https://doi.org/10.1007/s40629-015-0052-6
Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (. Allergo J Int. 2015;24(3):94-105. doi: 10.1007/s40629-015-0052-6. PMID: 26120552; PMCID: PMC4479479.
Copy Download .nbib Format: NLM
Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany.

Allergo journal international

Brehler R, Klimek L, Vogelberg C, Werfel T, Pfaar O, Hamelmann E.
PMID: 27226950
Allergo J Int. 2016;25:38-43. doi: 10.1007/s40629-016-0096-2. Epub 2016 Mar 23.

The recently published S2k-guideline on (allergen-) specific immunotherapy (AIT) provides an excellent overview of the evidence on allergen preparations available for AIT in Germany based on the published efficacy studies. Publications based on the guideline are currently being used...

Cite
Brehler R, Klimek L, Vogelberg C, et al. Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany. Allergo J Int. 2016;25:38-43doi: 10.1007/s40629-016-0096-2.
Brehler, R., Klimek, L., Vogelberg, C., Werfel, T., Pfaar, O., & Hamelmann, E. (2016). Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany. Allergo journal international, 2538-43. https://doi.org/10.1007/s40629-016-0096-2
Brehler, Randolf, et al. "Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany." Allergo journal international vol. 25 (2016): 38-43. doi: https://doi.org/10.1007/s40629-016-0096-2
Brehler R, Klimek L, Vogelberg C, Werfel T, Pfaar O, Hamelmann E. Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany. Allergo J Int. 2016;25:38-43. doi: 10.1007/s40629-016-0096-2. Epub 2016 Mar 23. PMID: 27226950; PMCID: PMC4861740.
Copy Download .nbib Format: NLM
Allergen immunotherapy for allergic asthma: protocol for a systematic review.

Clinical and translational allergy

Dhami S, Nurmatov U, Agache I, Lau S, Muraro A, Jutel M, Roberts G, Akdis C, Bonini M, Calderon M, Casale T, Cavkaytar O, Cox L, Demoly P, Flood B, Hamelmann E, Izuhara K, Kalayci Ö, Kleine-Tebbe J, Nieto A, Papadopoulos N, Pfaar O, Rosenwasser L, Ryan D, Schmidt-Weber C, Szefler S, Wahn U, van Wijk RG, Wilkinson J, Sheikh A.
PMID: 26862389
Clin Transl Allergy. 2016 Feb 09;6:5. doi: 10.1186/s13601-016-0094-y. eCollection 2015.

BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for Allergic Asthma. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in...

Cite
Dhami S, Nurmatov U, Agache I, et al. Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2016;6:5doi: 10.1186/s13601-016-0094-y.
Dhami, S., Nurmatov, U., Agache, I., Lau, S., Muraro, A., Jutel, M., Roberts, G., Akdis, C., Bonini, M., Calderon, M., Casale, T., Cavkaytar, O., Cox, L., Demoly, P., Flood, B., Hamelmann, E., Izuhara, K., Kalayci, �. �., Kleine-Tebbe, J., Nieto, A., Papadopoulos, N., Pfaar, O., Rosenwasser, L., Ryan, D., Schmidt-Weber, C., Szefler, S., Wahn, U., van Wijk, R. G., Wilkinson, J., & Sheikh, A. (2015). Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clinical and translational allergy, 65. https://doi.org/10.1186/s13601-016-0094-y
Dhami, Sangeeta, et al. "Allergen immunotherapy for allergic asthma: protocol for a systematic review." Clinical and translational allergy vol. 6 (2015): 5. doi: https://doi.org/10.1186/s13601-016-0094-y
Dhami S, Nurmatov U, Agache I, Lau S, Muraro A, Jutel M, Roberts G, Akdis C, Bonini M, Calderon M, Casale T, Cavkaytar O, Cox L, Demoly P, Flood B, Hamelmann E, Izuhara K, Kalayci Ö, Kleine-Tebbe J, Nieto A, Papadopoulos N, Pfaar O, Rosenwasser L, Ryan D, Schmidt-Weber C, Szefler S, Wahn U, van Wijk RG, Wilkinson J, Sheikh A. Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2016 Feb 09;6:5. doi: 10.1186/s13601-016-0094-y. eCollection 2015. PMID: 26862389; PMCID: PMC4746770.
Copy Download .nbib Format: NLM
Overlapping of two truncated crisis scenarios: generator of peaks in mean lifetimes of chaotic transients.

Physical review. E, Statistical, nonlinear, and soft matter physics

Paar V, Pavin N.
PMID: 14524883
Phys Rev E Stat Nonlin Soft Matter Phys. 2003 Sep;68(3):036222. doi: 10.1103/PhysRevE.68.036222. Epub 2003 Sep 30.

Maxima of mean transient time versus driving amplitude were found for weakly dissipated Duffing oscillator. In the neighborhood of peak of mean transient time an approximate power-law dependence was found. This behavior was compared with scaling in the vicinity...

Cite
Paar V, Pavin N. Overlapping of two truncated crisis scenarios: generator of peaks in mean lifetimes of chaotic transients. Phys Rev E Stat Nonlin Soft Matter Phys. 2003;68(3):036222doi: 10.1103/PhysRevE.68.036222.
Paar, V., & Pavin, N. (2003). Overlapping of two truncated crisis scenarios: generator of peaks in mean lifetimes of chaotic transients. Physical review. E, Statistical, nonlinear, and soft matter physics, 68(3), 036222. https://doi.org/10.1103/PhysRevE.68.036222
Paar, V, and Pavin, N. "Overlapping of two truncated crisis scenarios: generator of peaks in mean lifetimes of chaotic transients." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 68,3 (2003): 036222. doi: https://doi.org/10.1103/PhysRevE.68.036222
Paar V, Pavin N. Overlapping of two truncated crisis scenarios: generator of peaks in mean lifetimes of chaotic transients. Phys Rev E Stat Nonlin Soft Matter Phys. 2003 Sep;68(3):036222. doi: 10.1103/PhysRevE.68.036222. Epub 2003 Sep 30. PMID: 14524883.
Copy Download .nbib Format: NLM
Spin-isospin resonances and the neutron skin of nuclei.

Physical review letters

Vretenar D, Paar N, Niksić T, Ring P.
PMID: 14754046
Phys Rev Lett. 2003 Dec 31;91(26):262502. doi: 10.1103/PhysRevLett.91.262502. Epub 2003 Dec 29.

The Gamow-Teller resonances (GTR) and isobaric analog states (IAS) of a sequence of even-even Sn target nuclei are calculated by using the framework of the relativistic Hartree-Bogoliubov model plus proton-neutron quasiparticle random-phase approximation. The calculation reproduces the experimental data...

Cite
Vretenar D, Paar N, Niksić T, et al. Spin-isospin resonances and the neutron skin of nuclei. Phys Rev Lett. 2003;91(26):262502doi: 10.1103/PhysRevLett.91.262502.
Vretenar, D., Paar, N., Niksić, T., & Ring, P. (2003). Spin-isospin resonances and the neutron skin of nuclei. Physical review letters, 91(26), 262502. https://doi.org/10.1103/PhysRevLett.91.262502
Vretenar, D, et al. "Spin-isospin resonances and the neutron skin of nuclei." Physical review letters vol. 91,26 (2003): 262502. doi: https://doi.org/10.1103/PhysRevLett.91.262502
Vretenar D, Paar N, Niksić T, Ring P. Spin-isospin resonances and the neutron skin of nuclei. Phys Rev Lett. 2003 Dec 31;91(26):262502. doi: 10.1103/PhysRevLett.91.262502. Epub 2003 Dec 29. PMID: 14754046.
Copy Download .nbib Format: NLM
Diabetes-induced fetal growth retardation is associated with suppression of NF-kappaB activity in embryos.

The review of diabetic studies : RDS

Mammon K, Keshet R, Savion S, Pekar O, Zaslavsky Z, Fein A, Toder V, Torchinsky A.
PMID: 17491656
Rev Diabet Stud. 2005;2(1):27-34. doi: 10.1900/RDS.2005.2.27. Epub 2005 May 10.

BACKGROUND: Mechanisms underlying diabetes-induced fetal growth retardation remain largely undefined. Two events such as the persistent activation of apoptosis or suppression of cell proliferation in embryos might directly result in fetal growth retardation. Evidence implicating the transcription factor NF-kappaB...

Cite
Mammon K, Keshet R, Savion S, et al. Diabetes-induced fetal growth retardation is associated with suppression of NF-kappaB activity in embryos. Rev Diabet Stud. 2005;2(1):27-34doi: 10.1900/RDS.2005.2.27.
Mammon, K., Keshet, R., Savion, S., Pekar, O., Zaslavsky, Z., Fein, A., Toder, V., & Torchinsky, A. (2005). Diabetes-induced fetal growth retardation is associated with suppression of NF-kappaB activity in embryos. The review of diabetic studies : RDS, 2(1), 27-34. https://doi.org/10.1900/RDS.2005.2.27
Mammon, Keren, et al. "Diabetes-induced fetal growth retardation is associated with suppression of NF-kappaB activity in embryos." The review of diabetic studies : RDS vol. 2,1 (2005): 27-34. doi: https://doi.org/10.1900/RDS.2005.2.27
Mammon K, Keshet R, Savion S, Pekar O, Zaslavsky Z, Fein A, Toder V, Torchinsky A. Diabetes-induced fetal growth retardation is associated with suppression of NF-kappaB activity in embryos. Rev Diabet Stud. 2005;2(1):27-34. doi: 10.1900/RDS.2005.2.27. Epub 2005 May 10. PMID: 17491656; PMCID: PMC1762494.
Copy Download .nbib Format: NLM
[Introduction of new laboratory methods].

Casopis lekaru ceskych

PIHAR O, MINICHBAUER K, MIKETUKOVA V.
PMID: 18140628
Cas Lek Cesk. 1949 Aug 26;88(34):979-81.

No abstract available.

Cite
PIHAR O, MINICHBAUER K, MIKETUKOVA V. Poznamky k novým laboratornäm methodám. [Introduction of new laboratory methods]. Cas Lek Cesk. 1949;88(34):979-81
PIHAR, O., MINICHBAUER, K., & MIKETUKOVA, V. (1949). Poznamky k novým laboratornäm methodám. [Introduction of new laboratory methods]. Casopis lekaru ceskych, 88(34), 979-81.
PIHAR, O, et al. "Poznamky k novým laboratornäm methodám." [Introduction of new laboratory methods]. Casopis lekaru ceskych vol. 88,34 (1949): 979-81.
PIHAR O, MINICHBAUER K, MIKETUKOVA V. Poznamky k novým laboratornäm methodám. [Introduction of new laboratory methods]. Cas Lek Cesk. 1949 Aug 26;88(34):979-81. Undetermined. PMID: 18140628.
Copy Download .nbib Format: NLM
Probability densities for the sums of iterates of the sine-circle map in the vicinity of the quasiperiodic edge of chaos.

Physical review. E, Statistical, nonlinear, and soft matter physics

Afsar O, Tirnakli U.
PMID: 21230368
Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Oct;82(4):046210. doi: 10.1103/PhysRevE.82.046210. Epub 2010 Oct 11.

We investigate the probability density of rescaled sum of iterates of sine-circle map within quasiperiodic route to chaos. When the dynamical system is strongly mixing (i.e., ergodic), standard central limit theorem (CLT) is expected to be valid, but at...

Cite
Afsar O, Tirnakli U. Probability densities for the sums of iterates of the sine-circle map in the vicinity of the quasiperiodic edge of chaos. Phys Rev E Stat Nonlin Soft Matter Phys. 2010;82(4):046210doi: 10.1103/PhysRevE.82.046210.
Afsar, O., & Tirnakli, U. (2010). Probability densities for the sums of iterates of the sine-circle map in the vicinity of the quasiperiodic edge of chaos. Physical review. E, Statistical, nonlinear, and soft matter physics, 82(4), 046210. https://doi.org/10.1103/PhysRevE.82.046210
Afsar, Ozgur, and Tirnakli, Ugur. "Probability densities for the sums of iterates of the sine-circle map in the vicinity of the quasiperiodic edge of chaos." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 82,4 (2010): 046210. doi: https://doi.org/10.1103/PhysRevE.82.046210
Afsar O, Tirnakli U. Probability densities for the sums of iterates of the sine-circle map in the vicinity of the quasiperiodic edge of chaos. Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Oct;82(4):046210. doi: 10.1103/PhysRevE.82.046210. Epub 2010 Oct 11. PMID: 21230368.
Copy Download .nbib Format: NLM
Isospin mass splittings from precision measurements of D*-D mass differences.

Physical review letters

Acosta D, Akerib DS, Artuso M, Barish B, Barnes AV, Bartelt J, Battle M, Bean A, Bortoletto D, Brown DN, Chadha M, Cowen DF, Csorna SE, Dominick J, Egyed Z, Eigen G, Ernst J, Goldberg M, Gronberg J, Horwitz N, Jain V, Kennett R, Kroha H, Kutschke R, Masek G, McIlwain RL, Menary S, Miao T, Miller DH, Miller JS, Modesitt M, Moneti GC, Morrison RJ, Muheim F, Nelson H, Ong B, Paar H, Playfer S, Procario M, Richman J, Roberts S, Rozen Y, Rubin P, Sanghera S, Schaffner SF, Schmidt D, Sheldon P, Shibata EI, Shipsey IP, Sivertz M, Skwarnicki T, Sparks K, Sperka D, Stone S, Stroynowski R, Tajima H, Thorndike EH, Thulasidas M, Urheim J, Wang C, Weinstein AJ, Witherell M, Yao W, Zhu G.
PMID: 10046385
Phys Rev Lett. 1992 Oct 05;69(14):2046-2049. doi: 10.1103/PhysRevLett.69.2046.

No abstract available.

Cite
Acosta D, Akerib DS, Artuso M, et al. Isospin mass splittings from precision measurements of D*-D mass differences. Phys Rev Lett. 1992;69(14):2046-2049doi: 10.1103/PhysRevLett.69.2046.
Acosta, D., Akerib, D. S., Artuso, M., Barish, B., Barnes, A. V., Bartelt, J., Battle, M., Bean, A., Bortoletto, D., Brown, D. N., Chadha, M., Cowen, D. F., Csorna, S. E., Dominick, J., Egyed, Z., Eigen, G., Ernst, J., Goldberg, M., Gronberg, J., Horwitz, N., Jain, V., Kennett, R., Kroha, H., Kutschke, R., Masek, G., McIlwain, R. L., Menary, S., Miao, T., Miller, D. H., Miller, J. S., Modesitt, M., Moneti, G. C., Morrison, R. J., Muheim, F., Nelson, H., Ong, B., Paar, H., Playfer, S., Procario, M., Richman, J., Roberts, S., Rozen, Y., Rubin, P., Sanghera, S., Schaffner, S. F., Schmidt, D., Sheldon, P., Shibata, E. I., Shipsey, I. P., Sivertz, M., Skwarnicki, T., Sparks, K., Sperka, D., Stone, S., Stroynowski, R., Tajima, H., Thorndike, E. H., Thulasidas, M., Urheim, J., Wang, C., Weinstein, A. J., Witherell, M., Yao, W., & Zhu, G. (1992). Isospin mass splittings from precision measurements of D*-D mass differences. Physical review letters, 69(14), 2046-2049. https://doi.org/10.1103/PhysRevLett.69.2046
Acosta, et al. "Isospin mass splittings from precision measurements of D*-D mass differences." Physical review letters vol. 69,14 (1992): 2046-2049. doi: https://doi.org/10.1103/PhysRevLett.69.2046
Acosta D, Akerib DS, Artuso M, Barish B, Barnes AV, Bartelt J, Battle M, Bean A, Bortoletto D, Brown DN, Chadha M, Cowen DF, Csorna SE, Dominick J, Egyed Z, Eigen G, Ernst J, Goldberg M, Gronberg J, Horwitz N, Jain V, Kennett R, Kroha H, Kutschke R, Masek G, McIlwain RL, Menary S, Miao T, Miller DH, Miller JS, Modesitt M, Moneti GC, Morrison RJ, Muheim F, Nelson H, Ong B, Paar H, Playfer S, Procario M, Richman J, Roberts S, Rozen Y, Rubin P, Sanghera S, Schaffner SF, Schmidt D, Sheldon P, Shibata EI, Shipsey IP, Sivertz M, Skwarnicki T, Sparks K, Sperka D, Stone S, Stroynowski R, Tajima H, Thorndike EH, Thulasidas M, Urheim J, Wang C, Weinstein AJ, Witherell M, Yao W, Zhu G. Isospin mass splittings from precision measurements of D*-D mass differences. Phys Rev Lett. 1992 Oct 05;69(14):2046-2049. doi: 10.1103/PhysRevLett.69.2046. PMID: 10046385.
Copy Download .nbib Format: NLM
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.

Oncogenesis

Xu J, Pfarr N, Endris V, Mai EK, Md Hanafiah NH, Lehners N, Penzel R, Weichert W, Ho AD, Schirmacher P, Goldschmidt H, Andrulis M, Raab MS.
PMID: 28504689
Oncogenesis. 2017 May 15;6(5):e337. doi: 10.1038/oncsis.2017.36.

Multiple myeloma (MM) is a plasma cell malignancy that is still considered to be incurable in most cases. A dominant mutation cluster has been identified in RAS/RAF genes, emphasizing the potential significance of RAS/RAF/MEK/ERK signaling as a therapeutic target....

Cite
Xu J, Pfarr N, Endris V, et al. Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation. Oncogenesis. 2017;6(5):e337doi: 10.1038/oncsis.2017.36.
Xu, J., Pfarr, N., Endris, V., Mai, E. K., Md Hanafiah, N. H., Lehners, N., Penzel, R., Weichert, W., Ho, A. D., Schirmacher, P., Goldschmidt, H., Andrulis, M., & Raab, M. S. (2017). Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation. Oncogenesis, 6(5), e337. https://doi.org/10.1038/oncsis.2017.36
Xu, J, et al. "Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation." Oncogenesis vol. 6,5 (2017): e337. doi: https://doi.org/10.1038/oncsis.2017.36
Xu J, Pfarr N, Endris V, Mai EK, Md Hanafiah NH, Lehners N, Penzel R, Weichert W, Ho AD, Schirmacher P, Goldschmidt H, Andrulis M, Raab MS. Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation. Oncogenesis. 2017 May 15;6(5):e337. doi: 10.1038/oncsis.2017.36. PMID: 28504689; PMCID: PMC5523069.
Copy Download .nbib Format: NLM
[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology].

Pneumologie (Stuttgart, Germany)

Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupoldt A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A.
PMID: 30406626
Pneumologie. 2017 Dec;71(12):e3. doi: 10.1055/a-0790-0021. Epub 2018 Nov 07.

No abstract available.

Cite
Buhl R, Bals R, Baur X, et al. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. [Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology]. Pneumologie. 2018;71(12):e3doi: 10.1055/a-0790-0021.
Buhl, R., Bals, R., Baur, X., Berdel, D., Criée, C. P., Gappa, M., Gillissen, A., Greulich, T., Haidl, P., Hamelmann, E., Kardos, P., Kenn, K., Klimek, L., Korn, S., Lommatzsch, M., Magnussen, H., Nicolai, T., Nowak, D., Pfaar, O., Rabe, K. F., Riedler, J., Ritz, T., Schultz, K., Schuster, A., Spindler, T., Taube, C., Taube, K., Vogelmeier, C., von Leupoldt, A., Wantke, F., Weise, S., Wildhaber, J., Worth, H., & Zacharasiewicz, A. (2017). S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. [Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology]. Pneumologie (Stuttgart, Germany), 71(12), e3. https://doi.org/10.1055/a-0790-0021
Buhl, R, et al. "S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma." [Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology]. Pneumologie (Stuttgart, Germany) vol. 71,12 (2017): e3. doi: https://doi.org/10.1055/a-0790-0021
Buhl R, Bals R, Baur X, Berdel D, Criée CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupoldt A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. [Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology]. Pneumologie. 2017 Dec;71(12):e3. doi: 10.1055/a-0790-0021. Epub 2018 Nov 07. German. PMID: 30406626.
Copy Download .nbib Format: NLM
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.

JAMA

Rosenstock J, Kahn SE, Johansen OE, Zinman B, Espeland MA, Woerle HJ, Pfarr E, Keller A, Mattheus M, Baanstra D, Meinicke T, George JT, von Eynatten M, McGuire DK, Marx N.
PMID: 31536101
JAMA. 2019 Sep 24;322(12):1155-1166. doi: 10.1001/jama.2019.13772.

IMPORTANCE: Type 2 diabetes is associated with increased cardiovascular risk. In placebo-controlled cardiovascular safety trials, the dipeptidyl peptidase-4 inhibitor linagliptin demonstrated noninferiority, but it has not been tested against an active comparator.OBJECTIVE: This trial assessed cardiovascular outcomes of linagliptin...

Cite
Rosenstock J, Kahn SE, Johansen OE, et al. Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial. JAMA. 2019;322(12):1155-1166doi: 10.1001/jama.2019.13772.
Rosenstock, J., Kahn, S. E., Johansen, O. E., Zinman, B., Espeland, M. A., Woerle, H. J., Pfarr, E., Keller, A., Mattheus, M., Baanstra, D., Meinicke, T., George, J. T., von Eynatten, M., McGuire, D. K., Marx, N. (2019). Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial. JAMA, 322(12), 1155-1166. https://doi.org/10.1001/jama.2019.13772
Rosenstock, Julio, et al. "Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial." JAMA vol. 322,12 (2019): 1155-1166. doi: https://doi.org/10.1001/jama.2019.13772
Rosenstock J, Kahn SE, Johansen OE, Zinman B, Espeland MA, Woerle HJ, Pfarr E, Keller A, Mattheus M, Baanstra D, Meinicke T, George JT, von Eynatten M, McGuire DK, Marx N. Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial. JAMA. 2019 Sep 24;322(12):1155-1166. doi: 10.1001/jama.2019.13772. PMID: 31536101; PMCID: PMC6763993.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 282 entries